TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer. James ND, Liu W, Pirrie S, Kaur B, et al. BJU Int 2022 Jul 31. doi: 10.1111/bju.15864.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

James ND, Liu W, Pirrie S, Kaur B, et al. TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer. BJU Int 2022 Jul 31. doi: 10.1111/bju.15864.
PMID: 35908256